Up-regulation of estrogen receptor by tamoxifen in human breast cancer
Authors:
Open Access
Abstract
Background. Influence of tamoxifen treatment on estrogen receptor (ER) and progesterone receptor (PR) levels in human breast cancer has not been fully elucidated in vivo. This problem was studied in 20 postmenopausal patients with ER‐positive and PR‐positive primary breast cancer. Methods. Each patient underwent two fine‐needle aspiration (FNA) biopsies. Between two FNA, 10 patients received no treatment (control group) and the other 10 patients were given tamoxifen (20 mg/day) for an average of 8 days (range, 6–10 days) (TAM group). Total ER and PR values (cytosolic plus nuclear fraction) in FNA samples were determined by enzyme immunoassay (EIA) for detecting ER and PR regardless of their occupancy with corresponding ligands. Results. In the control group, no significant difference was found in ER and PR values between the first and second FNA samples. In the TAM group, ER and PR values (mean ± standard error of the mean [SEM] fmol/mg DNA) in the second FNA samples were 605 ± 186 and 1130 ± 344, respectively, and were significantly higher (P > 0.05) than ER and PR values in the first FNA samples, which were 312 ∓ 74 and 639 ± 159, respectively. ER and PR values increased by 201 ± 27% and 163 ± 23%, respectively, on an individual basis after tamoxifen treatment. Conclusions. These results demonstrated that tamoxifen up‐regulates ER and PR in human breast cancer.Keywords
This publication has 17 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Enzyme immunoassay of estrogen and progesterone receptors in drill biopsy specimens from breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Regulation of the Estrogen Receptor in MCF-7 Cells by EstradiolMolecular Endocrinology, 1988
- Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over timeCancer, 1988
- Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogensBiochemical and Biophysical Research Communications, 1987
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- A simple, rapid, and sensitive DNA assay procedureAnalytical Biochemistry, 1980
- Estrogen Control of Progesterone Receptor in Human Breast Cancer: Role of Estradiol and Antiestrogen*Endocrinology, 1978
- Hormones and Their Receptors in Breast Cancer1978
- Aspiration Biopsy in Diagnosis of Palpable Lesions of the Breast: Critical review of 3 479 consecutive biopsiesActa Radiologica: Therapy, Physics, Biology, 1968